Pharmacy Daily | AMA continues authority script push

Other recent headlines

• 

  Amcal diabetes risk scan

  Friday | Apr 20 2018

  AMCAL is offering its customers a health assessment with a focus on diabetes with its “personalised Diabetes Management Review” following the release of a new diabetes report from the company.

  
• 

  Pharmacist loses defamation case

  Friday | Apr 20 2018

  THE Federal Court of Australia has ruled against a WA pharmacist who claimed he was defamed by conditions being imposed on his registration and subsequent publication by the Pharmacy Board of Australia & the Australian Health Practitioner Regulatory Agency.

  
• 

  API addresses soft demand

  Thursday | Apr 19 2018

  AUSTRALIAN Pharmaceutical Industries has refined tactical sales activity and continues to develop exclusive products and range extensions, as part of a strategy to combat weak consumer demand which saw the company report a 24.9% decline in H1 net profit to $24.9 million (PD breaking news).